ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing

被引:87
|
作者
Nie, YZ
Ding, L
Kao, PN
Braun, R
Yang, JH [1 ]
机构
[1] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA
[2] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA
[3] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA
关键词
D O I
10.1128/MCB.25.16.6956-6963.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RNA-editing enzyme ADAR1 modifies adenosines by deamination and produces A-to-1 mutations in mRNA. ADAR1 was recently demonstrated to function in host defense and in embryonic erythropoiesis during fetal liver development. The mechanisms for these phenotypic effects are not yet known. Here we report a novel function of ADAR1 in the regulation of gene expression by interacting with the nuclear factor 90 (NF90) proteins, known regulators that bind the antigen response recognition element (ARRE-2) and have been demonstrated to stimulate transcription and translation. ADAR1 upregulates NF90-mediated gene expression by interacting with the NF90 proteins, including NF110, NF90, and NF45. A knockdown of NF90 with small interfering RNA suppresses this function of ADAR1. Coimmunoprecipitation and double-stranded RNA (dsRNA) digestion demonstrate that ADAR1 is associated with NF110, NF90, and NF45 through the bridge of cellular dsRNA. Studies with ADAR1 deletions demonstrate that the dsRNA binding domain and a region covering the Z-DNA binding domain and the nuclear export signal comprise the complete function of ADAR1 in upregulating NF90-mediated gene expression. These data suggest that ADAR1 has the potential both to change information content through editing of mRNA and to regulate gene expression through interacting with the NF90 family proteins.
引用
收藏
页码:6956 / 6963
页数:8
相关论文
共 50 条
  • [32] Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain
    Strehblow, A
    Hallegger, M
    Jantsch, MF
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (11) : 3822 - 3835
  • [33] Double-stranded RNA-induced iNOS expression by rat islets requires NF-κB activation
    Blair, LA
    Corbett, JA
    DIABETES, 1999, 48 : A243 - A243
  • [34] A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling
    Geiss, G
    Jin, G
    Guo, JJ
    Bumgarner, R
    Katze, MG
    Sen, GC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) : 30178 - 30182
  • [35] Adenosine deaminae (ADAR1) acting on double-stranded RNA and protein kinase PKR dependent on dsRNA as opposing modulators of antiviral innate immunity
    Samuel, C.
    CYTOKINE, 2012, 59 (03) : 492 - 493
  • [36] ADBP-1 Regulates an ADAR RNA-Editing Enzyme to Antagonize RNA-Interference-Mediated Gene Silencing in Caenorhabditis elegans
    Ohta, Hiromitsu
    Fujiwara, Manabi
    Ohshima, Yasumi
    Ishihara, Takeshi
    GENETICS, 2008, 180 (02) : 785 - 796
  • [37] Long non-coding RNA DANCR stabilizes HIF-1α and promotes metastasis by interacting with NF90/NF45 complex in nasopharyngeal carcinoma
    Wen, Xin
    Liu, Xu
    Mao, Yan-Ping
    Yang, Xiao-Jing
    Wang, Ya-Qin
    Zhang, Pan-Pan
    Lei, Yuan
    Hong, Xiao-Hong
    He, Qing-Mei
    Ma, Jun
    Liu, Na
    Li, Ying-Qin
    THERANOSTICS, 2018, 8 (20): : 5676 - 5689
  • [38] Viral Double-stranded RNA (DSRNA) Up-regulates mucin gene expression in human epithelial cells
    Londhe, VA
    Basbaum, CB
    PEDIATRIC RESEARCH, 2000, 47 (04) : 478A - 478A
  • [39] Dyschromatosis symmetrica hereditaria with chilblains due to a novel two-amino-acid deletion in the double-stranded RNA-binding domain of ADAR1
    Kono, M.
    Suganuma, M.
    Shimada, T.
    Ishikura, Y.
    Watanabe, S.
    Takeichi, T.
    Muro, Y.
    Akiyama, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (10) : E394 - E396
  • [40] Double-stranded RNA-induced iNOS expression and IL-1 release by murine macrophages requires NF-κ B activation
    Heitmeier, MR
    Scarim, AL
    Corbett, JA
    DIABETES, 1998, 47 : A232 - A232